(Q44236255)

English

Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

glycated hemoglobin

1 reference

object named as

glycosylated hemoglobin

23 October 2023

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Maribel Salas

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Alexandra Ward

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1690-1705

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes trends in the U.S.: 1990-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of undiagnosed diabetes mellitus: a US perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephropathy in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical review 51: Implications of the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct medical costs of complications resulting from type 2 diabetes in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Federal Budgetary Costs of Blindness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nursing home residents: a multivariate analysis of their medical, behavioral, psychosocial, and service use characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards of medical care for patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fundamentals of economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost to health plans of poor glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential short-term economic benefits of improved glycemic control: a managed care perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The progressive cost of complications in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980072-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)80072-8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44236255&oldid=2139471369"